author-photo

Aurélie Pailhé

4

Papers

52

Citations

Citation Trend

Filter By

Papers (4) Sort By

Journal Conference Others

Retreatment With Sofosbuvir Plus Grazoprevir/Elbasvir Plus Ribavirin of Patients With Hepatitis C Virus Genotype 1 or 4 Who Previously Failed an NS5A- or NS3-Containing Regimen: The ANRS HC34 REVENGE Study

2018 Clinical Infectious Diseases
Show All
- Source
- Cite
- Save
Citations (38)
Efficacy, safety and patient-reported outcomes of ledipasvir/sofosbuvir in NS3/4A protease inhibitor-experienced individuals with hepatitis C virus genotype 1 and HIV coinfection with and without cirrhosis (ANRS HC31 SOFTRIH study).

2018 Hiv Medicine
Show All
- Source
- Cite
- Save
Citations (10)
Retreatment with sofosbuvir plus grazoprevir plus elbasvir plus ribavirin of patients with Hepatitis C virus Genotype 1 or 4 with RASs at failure of a sofosbuvir plus ledipasvir or plus daclatasvir or plus simeprevir regimen (ANRS HC34 REVENGE study)

2016 Hepatology
Show All
- Source
- Cite
- Save
Citations (4)
Ledipasvir/Sofosbuvir in NS3/4A Protease Inhibitor-Experienced Subjects with HCV Genotype 1 and HIV-Co-Infection Final Results of the ANRS HC31 Softrih Study

2016 Journal of Hepatology
Show All
- Source
- Cite
- Save
Citations (0)